0
Sign In  | Subscribe

Chronic Kidney Disease Collection
 1-12 of 12 Articles
ACP Journal Club |  19 March 2013
Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
PDFPDF
Peter W. de Leeuw, MD
Ann Intern Med. 2013;158(6):JC7-. doi:10.7326/0003-4819-158-6-201303190-02007
ACP Journal Club |  20 November 2012
Review: Statins decrease mortality and major CV events in adults with CKD not receiving dialysis
PDFPDF
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-4. doi:10.7326/0003-4819-157-10-201211200-02004
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
PDFPDF
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
PDFPDF
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  20 November 2012
CKD-EPI eGFR categories were better than MDRD categories for predicting mortality in a range of populations
PDFPDF
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2012;157(10):JC5-12. doi:10.7326/0003-4819-157-10-201211200-02012
ACP Journal Club |  21 August 2012
Review: Antiplatelet therapy does not reduce mortality in chronic kidney disease
PDFPDF
Bernard G. Jaar, MD, MPH
Ann Intern Med. 2012;157(4):JC2-8. doi:10.7326/0003-4819-157-4-201208210-02008
ACP Journal Club |  20 December 2011
Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD
PDFPDF
Donald A. Molony, MD
Ann Intern Med. 2011;155(12):JC6-12. doi:10.7326/0003-4819-155-12-201112200-02012
ACP Journal Club |  15 November 2011
Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease
PDFPDF
Maurice Laville, MD
Ann Intern Med. 2011;155(10):JC5-2. doi:10.7326/0003-4819-155-10-201111150-02002
ACP Journal Club |  16 November 2010
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease
PDFPDF
Michael Walsh, MD, MSc
Ann Intern Med. 2010;153(10):JC5-2. doi:10.7326/0003-4819-153-10-201011160-02002
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
PDFPDF
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  16 April 2010
Review: Insufficient evidence exists on the benefit of vitamin D in patients with chronic kidney disease not requiring dialysis
PDFPDF
James B. Wetmore, MD
Ann Intern Med. 2010;152(8):JC4-12. doi:10.7326/0003-4819-152-8-201004200-02012
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
PDFPDF
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)